Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › VIP and VIP agonists, nanoparticles, and uses in inflammatory T-cell mediated disease

VIP and VIP agonists, nanoparticles, and uses in inflammatory T-cell mediated disease

US Patent 11786580 · Granted Oct 17, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Application of electrochemical impedance spectroscopy in sensor systems, devices2025
Burger press2025
Synthetic melanin nanoparticles and uses thereof2024
Compositions and uses of vasoactive intestinal peptide (VIP) antagonists2024
Compositions and uses of vasoactive intestinal peptide (VIP) antagonists2024
Anti-CD137 antibodies for combination with anti-PD-L1 antibodies2024
Methods of treating cancer using cell based therapies2024
Nanoparticles conjugated with vasoactive intestinal peptide antagonists2023
VIP antagonists and uses in treating cancer2022
Antagonism of the VIP signaling pathway2022
Anti-PD-L1-anti-TIM-3 bispecific antibodies2022
Anti-Tim-3 antibodies for combination with anti-PD-1 antibodies2022